Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
352.3 EUR | -0.93% | +0.17% | +2.56% |
17/06 | Wedbush Adjusts Price Target on argenx to $519 From $521, Maintains Outperform Rating | MT |
13/06 | Pliant Therapeutics, Inc. Appoints Steve Krognes to Its Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.56% | 2.27TCr | |
+16.61% | 12TCr | |
+19.11% | 11TCr | |
-16.35% | 2.13TCr | |
-39.57% | 1.69TCr | |
-13.93% | 1.67TCr | |
-16.22% | 1.66TCr | |
+3.01% | 1.36TCr | |
+21.82% | 1.1TCr | |
+108.65% | 1.04TCr |
- Stock Market
- Equities
- ARGX Stock
- News argenx SE
- Argenx Names Karen Massey as Chief Operating Officer